PT - JOURNAL ARTICLE AU - Ensser, Armin AU - Überla, Pia AU - Überla, Klaus TI - Modest effects of contact reduction measures on the reproduction number of SARS-CoV-2 in the most affected European countries and the US AID - 10.1101/2020.04.20.20067538 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.20.20067538 4099 - http://medrxiv.org/content/early/2020/04/24/2020.04.20.20067538.short 4100 - http://medrxiv.org/content/early/2020/04/24/2020.04.20.20067538.full AB - Population density, behaviour and cultural habits strongly influence the spread of pathogens. Consequently, key epidemiological parameters may vary from country to country. Many estimates of SARS-CoV-2 and COVID-19 strongly depend on testing frequency and case definitions. The fatal cases due to SARS-CoV2 could be a more reliable parameter, since missing of deaths is less likely. We analysed the dynamics of new infection and death cases to estimate the daily reproduction numbers (Rt) and the effectiveness of control measures in the most affected European Countries and the US. In summary, calculating Rt based on the daily number of deaths as well as of new infections may lead to more reliable estimates than those based on infection cases alone, as death based Rt are expected to be less susceptible to testing bias or limited capacities.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno external funding was receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are publicly available